Schedule 13D ownership disclosure
MYMD PHARMACEUTICALS INC
Security class unavailable · CUSIP: 62856X102
Event date: 2021-04-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,020,181
- Percent of class
- 13.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897069-21-000187
- Form type
- SC 13D
- Filer
- Q/C TECHNOLOGIES, INC.
- CIK
- CIK 1321834
- Filed
- Apr 27, 2021
- Reporting period
- Apr 16, 2021
- Description
- Schedule 13D beneficial ownership